⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10017886 | 1.00 | — | — | |
| SCHEMBL19447936 | 1.00 | — | — | |
| SCHEMBL17126836 | 1.00 | — | — | |
| SCHEMBL17069142 | 1.00 | — | — | |
| SCHEMBL12410329 | 0.96 | CYP2C19 (0.31) | — | |
| SCHEMBL17694160 | 0.96 | CYP2C19 (0.31) | — | |
| SCHEMBL15910073 | 0.77 | CYP2C19 (0.33) | — | |
| SCHEMBL14557461 | 0.77 | CYP2C19 (0.33) | — | |
| SCHEMBL12410331 | 0.77 | CYP2C19 (0.33) | — | |
| SCHEMBL30930086 | 0.74 | CYP2C19 (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240217990-A1 | THIENOPYRROLE COMPOUNDS | GILEAD SCIENCES, INC. | 2024-07-04 | — | — | US | disclosed |
| US-20230365594-A1 | THIENOPYRROLE COMPOUNDS | GILEAD SCIENCES, INC. | 2023-11-16 | — | — | US | disclosed |
| US-11787825-B2 | Therapeutic compounds for HIV virus infection | GILEAD SCIENCES, INC. (US) | 2023-10-17 | — | — | US | disclosed |
| US-20230270734-A1 | THIENOPYRROLE COMPOUNDS | GILEAD SCIENCES, INC. | 2023-08-31 | — | — | US | disclosed |
| US-20230212148-A1 | THERAPEUTIC COMPOUNDS FOR HIV VIRUS INFECTION | GILEAD SCIENCES, INC. | 2023-07-06 | — | — | US | disclosed |
| US-20230203069-A1 | THERAPEUTIC COMPOUNDS FOR HIV VIRUS INFECTION | GILEAD SCIENCES, INC. | 2023-06-29 | — | — | US | disclosed |
| US-20230203071-A1 | THERAPEUTIC COMPOUNDS FOR HIV VIRUS INFECTION | GILEAD SCIENCES, INC. | 2023-06-29 | — | — | US | disclosed |
| US-11661431-B2 | Thienopyrrole compounds | GILEAD SCIENCES, INC. (US) | 2023-05-30 | — | — | US | disclosed |
| WO-2020239593-A1 | SILYL TERMINATED PREPOLYMER AND COMPOSITION COMPRISING THE SAME | SOPREMA (FR) | 2020-12-03 | — | — | WO | disclosed |
| WO-2020239596-A1 | PREPOLYMER AND COMPOSITION COMPRISING THE SAME | SOPREMA (FR) | 2020-12-03 | — | — | WO | disclosed |
| WO-2020239592-A1 | SILYL TERMINATED PREPOLYMER AND COMPOSITION COMPRISING THE SAME | SOPREMA (FR) | 2020-12-03 | — | — | WO | disclosed |
| WO-2020239595-A1 | AMINE TERMINATED PREPOLYMER AND COMPOSITION COMPRISING THE SAME | SOPREMA (FR) | 2020-12-03 | — | — | WO | disclosed |
| WO-2020239594-A1 | AMINE TERMINATED PREPOLYMER AND COMPOSITION COMPRISING THE SAME | SOPREMA (FR) | 2020-12-03 | — | — | WO | disclosed |
| US-20170349539-A1 | POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, AND OPTICALLY ANISOTROPIC SUBSTANCE | ZEON CORPORATION (JP) | 2017-12-07 | — | — | US | disclosed |
| US-9776954-B2 | Polymerizable compound, polymerizable composition, polymer, and optically anisotropic substance | ZEON CORPORATION (JP) | 2017-10-03 | — | — | US | disclosed |
| US-20150274647-A1 | POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, AND OPTICALLY ANISOTROPIC SUBSTANCE | ZEON CORPORATION (JP) | 2015-10-01 | — | — | US | disclosed |
| US-8188089-B2 | Tylophorine analogs as antitumor agents | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2012-05-29 | — | — | US | disclosed |
| US-20120029018-A1 | 9-SUBSTITUTED PHENANTHRENE BASED TYLOPHORINE DERIVATIVES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2012-02-02 | — | — | US | disclosed |
| US-20110166127-A1 | Substituted Benzo-Pyrimido-Tetrazolo-Diazepine Compounds | ARQULE, INC. (US) | 2011-07-07 | — | — | US | disclosed |